AV
Avacta Group Plc
AVCTF · OTC
$0.97 +1.57% (+$0.02)
1M +7.78%
Market Cap £336.5M
P/E Ratio -
Div. Yield -
ROE 255.53%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 2,978.60x
P/B 135.94x
P/E N/A
Growth
0 /100
Declining Rev. growth 77.30%
Book val. growth 48.79%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 1,031.86%
FCF margin 21,950.60%
Net margin 33,961.30%
Quality
0 /100
Poor ROIC 172.01%
Asset turnover 0.00x
ROE 255.53%
Debt
7 /100
High Debt/Equity 6.02x
Int. coverage -4.29x
Current ratio 0.89x
Stability
19 /100
Unstable Beta -0.10x
Profitable years 0
Rev. volatility 120.76%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AVCTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christina Marie Coughlin
Employees
154
Headquarters
London
Nadcházející události
05 ŘÍJ
Earnings
Upcoming earnings report